MD net
Active Awarded Last action
- Contract number
- 75N91019F00139
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $181,379,395
Award facts
- Opportunity
-
- N02CO7240681 Solicitation number
- Contract value 100% obligated
- $181,379,395.00 Current and potential, with all options
- Completion date 70% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $17,907,031 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $41,926,860 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $6,046,167 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $36,415,386 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $79,083,951 |
Show all 14
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 26, 2019, under the MD NET indefinite delivery contract with a ceiling value of $181.4 million and ultimate completion date of October 31, 2029.
MD NET is a cost-plus-fixed-fee vehicle supporting biomedical research and facilities operations at the Frederick National Laboratory for Cancer Research. Place of performance is Frederick, MD 21702.
Leidos Biomedical Research operates the Frederick National Laboratory on behalf of NCI and delivers research execution, facilities infrastructure management, clinical trial support, and specialized manufacturing across multiple scientific domains. Work extends to subordinate NIH institutes and collaborative sites.
Service Contract Inventory reporting captures this order's government-invoiced activity at $106.7 million across fiscal years 2021 through 2025. FY2024 represented peak utilization at $45.8 million invoiced across 100 FTEs and 209,088 contractor hours, with a blended government-paid hourly rate of $219.15/hr. FY2025 activity declined to $23.2 million invoiced, 63.7 FTEs, and 132,503 contractor hours at $175.34/hr. In FY2025, subcontractors supplied 65 percent of contractor hours across nine named vendors. The trend across the reporting period shows volatility in utilization and labor rates, with significant staffing drawdown from FY2024 to FY2025.
Quick answers
Who was awarded contract 75N91019F00139?
75N91019F00139 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 26, 2019.
How much is contract 75N91019F00139 worth?
The government has obligated $181,379,395 on 75N91019F00139.
Is contract 75N91019F00139 an order under another contract?
Yes. 75N91019F00139 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91019F00139 competed?
The extent of competition for 75N91019F00139 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award